Class IICompleted

Avastin 1.25 mg/0.05 mL in 0.25 mL Syringe recall

FDA recall D-0248-2025 · initiated Feb 18, 2025

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Lack of Assurance of Sterility: due to a quality control process deviation

Details

Product: Avastin 1.25 mg/0.05 mL in 0.25 mL Syringe, For Intravitreal Injection Only, Office Use Only - Not for Resale - Single Use, This drug product was repackaged by Turbare Manufacturing, 925 Jeanette Drive, Conway, AR 72032, NDC: 83556-0101-01.
Recalling company: Turbare Manufacturing
Classification: Class II
Status: Completed
Type: Voluntary: Firm initiated
Distribution: Nationwide in the USA
Initiated: Feb 18, 2025
FDA report date: Mar 5, 2025

What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Source: openFDA Drug Enforcement record D-0248-2025 ↗

← All drug recalls